Sarepta Therapeutics (SRPT) Sees Intra-Day Selling Pressure
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Sarepta Therapeutics (NASDAQ: SRPT) seeing notable intra-day pressure. Shares down 3.2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Exondys 51 'Medically Necessary' at Aetna When Certain Criteria are Met
- Stocks with call price movement; USO TWTR
- Under Armour (NYSE: UA) volatility low as shares trade near 52-week low